CD19 and diffuse large B-cell lymphoma: Our data indicated that DSF or DSF/Cu decrease the CD19+ B cells and their mitochondrial membrane potential and induced their apoptosis (Fig. 7A–C), suggesting that DSF or DSF/Cu could induce the apoptosis of primary DLBCL cells and may have a therapeutic effect on DLBCL patients.